Capecitabine 150 mg/1

Capecitabine 150 mg tablets are an oral medication used in cancer treatment. This film-coated tablet is manufactured by Teva Pharmaceuticals USA, Inc. and is available in a 60-tablet bottle.

Capecitabine is primarily used in the treatment of certain types of cancer. It is often prescribed for colorectal cancer and breast cancer, among other indications. The medication works by interfering with the growth of cancer cells, helping to slow or stop their spread. Patients should consult their healthcare provider to determine if Capecitabine is suitable for their specific condition.

Common effects of Capecitabine may include nausea, vomiting, diarrhea, and fatigue. Some patients may also experience hand-foot syndrome, which is characterized by redness, swelling, and peeling of the skin on the palms and soles. These effects can vary in severity and may require medical attention if they become severe or persistent.

Capecitabine should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their healthcare provider about any existing medical conditions or allergies before starting Capecitabine. Pregnant women or those planning to become pregnant should discuss the potential risks with their doctor.

Capecitabine may interact with other medications, including certain chemotherapy drugs and blood thinners. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be avoided while taking Capecitabine, as it may increase the risk of side effects.